London-Based Reformed Raises $22 Million in Series A Funding
Reformed, a London-based company specializing in wellness beverages, has successfully secured $22 million in a Series A funding round. The round, which closed on July 13, 2026, was led by IRIS Ventures. Additional investment came from JamJar Investments, V3 Ventures, and Food Labs.
Innovative Wellness Beverages
Reformed has carved out a niche in the wellness market by offering Arabica coffee and ceremonial matcha that are enriched with functional ingredients like collagen, creatine, adaptogens, and a blend of twenty-one vitamins. This unique approach aims to cater to health-conscious consumers looking for more than just a caffeine fix.
Leadership and Vision
Neil Marrakchi, co-founder of Reformed, has been pivotal in steering the company's innovative approach to wellness beverages. "We are thrilled to have the support of such esteemed investors as we continue to expand our offerings and reach new markets," Marrakchi remarked.
Use of Funds
The newly acquired funds are expected to be used for expanding Reformed's product line and increasing its market presence both locally and internationally. The company also plans to invest in enhancing its production capabilities to meet growing consumer demand.
Investor Confidence
The involvement of prominent investors like IRIS Ventures and others underscores the confidence in Reformed's business model and its potential for growth in the competitive wellness sector. This funding round marks a significant step forward in the company's journey to becoming a leader in the functional beverage market.
Looking Ahead
With the Series A funding secured, Reformed is well-positioned to enhance its product offerings and expand its reach in the wellness market. The company is set to leverage this capital infusion to further its mission of providing innovative and health-focused beverage options.